07/13/2026
Digital pathology is moving from "nice to have" to enterprise necessity, but scanners and storage alone won't get labs there. A new review lays out a full lifecycle framework for sustainable DP adoption, covering workflow redesign, validation, interoperability, cybersecurity, and institutional AI readiness. The authors stress a key distinction: regulatory clearance is not the same as laboratory validation and ongoing quality management. For pathology departments navigating the shift to digital, this offers a practical roadmap for building lasting, innovation-ready programs.
Read more:
Digital pathology (DP) is transitioning from an adjunct technology to an enterprise diagnostic platform in the United States. Despite accelerating clinical adoption, many laboratories face persistent barriers, including high capital and operating costs, workflow disruption, interoperability challeng...